News Detail
New Delhi, 15 April 2023: The NITI Ayog has said that Indian drug regulatory standards should be on par with global standards. It has also recommended that medical devices should be overseen by a separate authority and not by the Drugs Controller General of India (DCGI).
Source : PTI with Inputs from Outlook
NITI Ayog
Indian drug regulatory standards
global standards
medical devices
separate authority
Drugs Controller General of India (DCGI)
inter-ministerial consultation
New Drugs
Medical Devices and Cosmetics Bill 2023
Drugs and Cosmetics Act of 1940
ICH guidelines for clinical trials
timeliness of decisions
promoting access of new therapies/drugs
several scandals
children deaths in Gambia and Uzbekistan
Indian Pharmacopoeia
CDSCO
Related News
- In Sriganganagar and Raisinghnagar, One family is running a dirty business of drugs (22-09-2023)
- Four persons involved in cheating in the name of fake pharma company arrested (22-09-2023)
- Two patients' health deteriorated after injection in Halat Hospital, Kanpur (22-09-2023)
- SEC recommends permission for phase I trial of Cadila Pharma's VZV vaccine (22-09-2023)
- Adding preservatives to ayurvedic medicine will change the classification of medicine (22-09-2023)
- 50 children fell ill after taking filariasis medicine in Purnia (21-09-2023)
- Two smuggling gang youths arrested, one thousand intoxicating pills recovered (21-09-2023)
- FSDA Meerut team raided Transport Godown in Hapur to check consignment of Phensedyl (21-09-2023)
- NMC gets WFME Recognition for 10 Years (21-09-2023)
- Govt approved ₹480 crore to develop talent pool for medical devices sector (21-09-2023)